-
RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Strengthening Ties in Regenerative Medicine: Reflecting on the Japan–Netherlands Mission
On 15-16 October 2025 RegMed XB welcomed the Nakanoshima Qross Delegation from Japan. Nakanoshima Qross is a translational hub for Regenerative Medicine based in Osaka.
read more
Save the date! RegMed XB 4th Annual Conference
Save the Date! Join us for an exciting community event on June 10th and 11th, covering the entire spectrum of regenerative medicine, from cutting-edge research to practical solutions.
read more
Thematic Tech Transfer (TTT) Program Awarded
DCVA (Dutch Cardiovascular Alliance), RegMed XB, BioGeneration Ventures (BGV) and its fund FIRST proudly announce that their joint Thematic Tech Transfer (TTT) program has been awarded €10 million in funding by the Netherlands Enterprise Agency (RVO), on behalf of the Ministry of Economic Affairs.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read more -
-
-
-
-
-
-
